Novel curcumin-resveratrol solid nanoparticles synergistically inhibit proliferation of melanoma cells
In addition, the LIRA-FLAME trial (NCT03449654) is examining the effects of liraglutide vs
In parallel, LPS and inflammation perturb hepatic clock gene expression and time-of-day responses (for example altering Per and, in specific contexts, BMAL1 expression), which further deranges metabolic rhythmicity and amplifies vulnerability to steatotic progression
This could theoretically alter the peak plasma concentration (Cmax) and time to peak concentration (Tmax) of co-administered oral drugs
More directly, tumors shed bioactive lipids to engage specific extracellular receptors on immune cells [135, 148,149,150,151]